The Board at its meeting held today have approved appointment of M/s M K Saraf & Associates LLP, practising company secretaries as the secretarial auditors for a period of five years effective ....
Awaiting price reaction for this filing.
The Board of Directors of Procter & Gamble Hygiene and Health Care Limited approved audited financial results for the nine-month period ended March 31, 2025 (the company changed its financial year-end from June 30 to March 31, making this a transitional 9-month period). Revenue from operations for the nine months stood at Rs. 3,37,442 lakhs with a profit of Rs. 63,859 lakhs and basic/diluted EPS of Rs. 196.11. The Board recommended a final dividend of Rs. 65 per share (face value Rs. 10), totaling about Rs. 21,099 lakhs, to be paid between August 27 and September 23, 2025, subject to AGM approval. Statutory auditors Kalyaniwalla & Mistry LLP issued an unmodified opinion on the results. The Board also appointed M/s M K Saraf & Associates LLP as Secretarial Auditors for a five-year term from April 1, 2025 to March 31, 2030, subject to member approval.
Shareholders stand to receive a Rs. 65 final dividend per share, signaling continued cash returns from the company, while the financial year change makes current figures non-comparable with the prior year, so investors should focus on the nine-month absolute performance rather than year-on-year growth comparisons.